DE3164143D1 - Production of viral antigens - Google Patents

Production of viral antigens

Info

Publication number
DE3164143D1
DE3164143D1 DE8181302947T DE3164143T DE3164143D1 DE 3164143 D1 DE3164143 D1 DE 3164143D1 DE 8181302947 T DE8181302947 T DE 8181302947T DE 3164143 T DE3164143 T DE 3164143T DE 3164143 D1 DE3164143 D1 DE 3164143D1
Authority
DE
Germany
Prior art keywords
cells
respiratory syncytial
syncytial virus
produced
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181302947T
Other languages
English (en)
Inventor
Edward James Stott
Lewis Hartland Thomas
Norma Jean Jebbett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Application granted granted Critical
Publication of DE3164143D1 publication Critical patent/DE3164143D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation
    • C12N2760/18564—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8181302947T 1980-07-01 1981-06-29 Production of viral antigens Expired DE3164143D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8021434 1980-07-01

Publications (1)

Publication Number Publication Date
DE3164143D1 true DE3164143D1 (en) 1984-07-19

Family

ID=10514423

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181302947T Expired DE3164143D1 (en) 1980-07-01 1981-06-29 Production of viral antigens

Country Status (11)

Country Link
US (2) US4517304A (de)
EP (1) EP0043272B1 (de)
JP (2) JPS5740412A (de)
AT (1) ATE7855T1 (de)
AU (2) AU554080B2 (de)
CA (1) CA1188985A (de)
DE (1) DE3164143D1 (de)
GB (1) GB2079786B (de)
NL (1) NL300020I2 (de)
NZ (1) NZ197553A (de)
ZA (1) ZA814386B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
US4814269A (en) * 1985-03-29 1989-03-21 Cenfold Holdings S.A. Diagnostic testing for antibodies against microorganisms
US5149650A (en) * 1986-01-14 1992-09-22 University Of North Carolina At Chapel Hill Vaccines for human respiratory virus
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
US5824307A (en) 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
DE4207317C3 (de) * 1992-03-06 2000-03-16 Heraeus Electro Nite Int Vorrichtung zur Messung der Temperatur von Metallschmelzen
ATE249838T1 (de) 1993-05-12 2003-10-15 Chiron Corp Konserviertes motiv der hepatitis c virus e2/ns1 region
AU676340B2 (en) † 1993-05-25 1997-03-06 Wyeth Holdings Corporation Adjuvants for vaccines against respiratory syncytial virus
US7223410B1 (en) 1994-08-05 2007-05-29 Sanofi Pasteur Limited Inactivated respiratory syncytial viral vaccines
EP0714306B1 (de) * 1993-08-06 1998-03-25 Connaught Laboratories Limited Inaktivierte respiratorische synzytial-virus-impfstoffe
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
GB9924990D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Medicaments
US7943153B1 (en) 1999-11-08 2011-05-17 Biomune Vaccines for Mycoplasma bovis and methods of use
ES2349348T3 (es) * 2000-01-27 2010-12-30 Medimmune, Llc Anticuerpos neutralizantes de rsv de ultra alta afinidad.
ES2390761T3 (es) * 2000-03-01 2012-11-16 Medimmune, Llc Anticuerpos recombinantes de alta potencia y método para producción de los mismos
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
WO2006050166A2 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226743A (de) * 1967-04-19 1971-03-31
US3919044A (en) * 1973-03-28 1975-11-11 Armour Pharma Processes for concentrating and purifying viruses and viral antigens
FR2227861B1 (de) * 1973-05-04 1976-07-02 Anvar
US4112068A (en) * 1976-08-11 1978-09-05 Cutter Laboratories, Inc. Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom
NL7801060A (nl) * 1977-02-09 1978-08-11 Merck & Co Inc Werkwijze voor het bereiden van een afgezwakt syncytiaal ademhalingsvirus, alsmede prepara- ten en vaccins die dit virus bevatten.
US4122167A (en) * 1977-02-09 1978-10-24 Merck & Co., Inc. Respiratory synctial vaccine
LU79503A1 (fr) * 1977-08-17 1978-11-28 Merck & Co Inc Procede de preparation d'un vaccin syncytial du virus respiratoire

Also Published As

Publication number Publication date
NL300020I2 (nl) 2001-08-01
JPH0380474B2 (de) 1991-12-25
NL300020I1 (nl) 2000-12-01
AU5841286A (en) 1986-11-20
EP0043272A1 (de) 1982-01-06
JPS5740412A (en) 1982-03-06
JPH0553474B2 (de) 1993-08-10
EP0043272B1 (de) 1984-06-13
NZ197553A (en) 1985-03-20
AU7241581A (en) 1982-01-07
CA1188985A (en) 1985-06-18
GB2079786B (en) 1984-11-14
AU588885B2 (en) 1989-09-28
US5071758A (en) 1991-12-10
US4517304A (en) 1985-05-14
JPH02291262A (ja) 1990-12-03
AU554080B2 (en) 1986-08-07
ATE7855T1 (de) 1984-06-15
ZA814386B (en) 1982-07-28
GB2079786A (en) 1982-01-27

Similar Documents

Publication Publication Date Title
GB2079786B (en) Production of viral antigens
NZ224581A (en) Hiv-2 peptide, aids vaccine
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
FI93310B (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
DE69327623D1 (de) Herstellungsmethode um multiple-sklerose-virus-assoziierte infizierte zellen zu erhalten
AU5329279A (en) Feline infectious peritonitis vaccine
IE860315L (en) Detecting htlv-iii neutralising antibodies
ES469937A1 (es) Procedimiento para preparar una nueva cepa del virus de la rabia.
ES8200398A1 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
ES8404856A1 (es) Metodo de preparacion de una vacuna contra un virus de adn.
TH13250EX (th) เชื้อไวรัสที่เกี่ยวกับโรคซึ่งเกิดกับหมูโดยไม่ทราบสาเหตุ
UA8704A1 (uk) Спосіб визhачеhhя аhтигеhhої hовими вірусу грипу
EP0236058A3 (en) Vaccine against herpes simplex
AU2713488A (en) Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process
IT1165451B (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo
JPS6485092A (en) Production of protein
ES446396A1 (es) Procedimiento para preparar vacunas estimulantes de la pro- duccion de anticuerpos contra virus.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BRITISH TECHNOLOGY GROUP LTD., LONDON, GB